Thrombosis associated with medical devices may lead to dramatic increases in morbidity,
mortality and increased health care costs. Innovative strategies are being developed to …

The use of biomaterials in implanted medical devices remains hampered by platelet
adhesion and blood coagulation. Thrombus formation is a prevalent cause of failure of these …

Blood‐contacting medical devices, such as vascular grafts, stents, heart valves, and
catheters, are often used to treat cardiovascular diseases. Thrombus formation is a common …

Surface-induced thrombosis is a frequent, critical issue for blood-contacting medical devices
that poses a serious threat to patient safety and device functionality. Antithrombotic material …

Blood-contacting medical devices of different biomaterials are often used to treat various
cardiovascular diseases. Thrombus formation is a common cause of failure of …

No currently available artificial surface is completely inert toward blood; accordingly,
thrombosis and thromboembolism complicate to some extent the use of all bloodcontacting …

Our failure to produce truly non-thrombogenic materials may reflect a failure to fully
understand the mechanisms of biomaterial-associated thrombosis. The community has …

Although significant progress has been made in the design of blood-compatible polymers in
the past decades, there is no ideal polymer surface which is comparable with a natural …

Thromboembolic and infectious complications stemming from the use of cardiovascular
medical devices are still common and result in significant morbidity and mortality. There is …

Blood-contacting medical devices are an integral part of modern medicine. Such devices
may be used for only a few hours or may be implanted for life. Despite advances in …